METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF Read more about METHODS OF PRODUCING T CELL POPULATIONS USING HYDROXYCITRIC ACID AND/OR A SALT THEREOF Hong Kong62021038049.4Filed on 2021-09-02
T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS Read more about T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS New Zealand779633Filed on 2021-09-02
T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS Read more about T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS China202111083392.9Filed on 2021-09-15
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN India202148039207Filed on 2021-08-30
CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY Read more about CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY US Application 17/475,810Filed on 2021-09-15
Use Of TomentosenalA For Treatment Of Skin Conditions Read more about Use Of TomentosenalA For Treatment Of Skin Conditions Australia2021902329Filed on 2021-07-29
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 South Korea10-2021-7029207Filed on 2021-09-10
T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 Read more about T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 China202111028896.0Filed on 2021-09-01
PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Read more about PLK1 POLO BOX DOMAIN INHIBITOR AND METHOD OF TREATING CANCER Patent Cooperation TreatyPCT/US2021/052054Filed on 2021-09-24
CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY Read more about CHIMERIC ADAPTOR AND KINASE SIGNALING PROTEINS AND THEIR USE IN IMMUNOTHERAPY China202080021582.5Filed on 2020-03-13